Send me a link:

*Text messaging rates may apply.

 Dow Up 0.08% Nasdaq Down 0.08%

Celgene Corporation (CELG)

-NasdaqGS
85.07 Down 4.05(4.54%) 10:30AM EDT - Nasdaq Real Time Price
Prev Close:89.12
Open:87.26
Bid:84.72 x 100
Ask:84.74 x 200
1y Target Est:95.18
Beta:1.11
Next Earnings Date:24-Jul-14CELG Earnings announcement
Day's Range:84.26 - 90.10
52wk Range:65.76 - 90.50
Volume:3,222,019
Avg Vol (3m):5,111,380
Market Cap:68.13B
P/E (ttm):27.08
EPS (ttm):3.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CELG

Comparison

Symbol% ChgMkt Cap
CELGDown 4.54%68.13B
JNJUp 0.13%289.47B

Key Statistics

Forward P/E (1 yr):17.54
P/S (ttm):10.56
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.67
Quarterly EPS Est (Jun-14) :0.89
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.96

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback